Duloxetine- A novel therapeutic regimen for trigeminal neuralgia

Abstract

Duloxetine is a potent and selective inhibitor of serotonin and noradrenaline transporters and a weak inhibitor of dopamine transporters. Duloxetine is highly protein bound and is widely distributed throughout tissues. It is rapidly and extensively metabolized in the liver by cytochrome P450 (CYP) 1A2 and 2D6 and its numerous metabolites which are inactive are mainly excreted in the urine. It is more effective for recurrent/refractory type of TN. Duloxetine holds the promise in complete remission of TN in future. So in coming days it may be a drug of choice for medical management of TN. This article is an insight in chemical features, pharmacodynamics, pathophysiology and therapeutics of Duloxetine.

Authors and Affiliations

Akhilanand Chaurasia

Keywords

Related Articles

An adamant entity of oral cavity – A case report of Proliferative verrucous leukoplakia with review of literature

Hansen et al first described proliferative verrucous leukoplakia (PVL) in the year of 1985. It is a rare form of oral leukoplakia which occurs as a slow growing and becomes multifocal and as the time progresses it become...

The oroantral fistula: A case report

Introduction: An unnatural communication between the maxillary sinus and oral cavity is known as “oro-antral communication”(OAC) and if it does not close spontaneously, it is epithelialized so that oroantral fistula deve...

Lateral Compression Open Cap Splint (MacLennan) - A Treatment Modality for Pediatric Mandibular Parasymphysis Fracture: Case Report

Facial injuries are the most disturbing situations in pediatric patients. The treatment options for the traumatic injuries in pediatric group is controversial as any surgical intervention in young children may disturb th...

Tubercular osteomyelitis of the mandible– A case report

Tuberculosis of jaw is an extremely rare condition, particularly in comparison to pulmonary tuberculosis. It is a diagnostic enigma, as the characteristic signs and symptoms of this disease may be absent, or sometimes ra...

Bacteria in oral carcinogenesis

Cancer is a subject that has got enormous depth and we clinicians are still searching for the end point The multi centric etiopathogenesis of cancer makes it a field of enormous research Bacteria meanwhile have been seen...

Download PDF file
  • EP ID EP295530
  • DOI 10.18231/2395-6194.2017.0053
  • Views 112
  • Downloads 0

How To Cite

Akhilanand Chaurasia (2017). Duloxetine- A novel therapeutic regimen for trigeminal neuralgia. Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology, 3(4), 222-224. https://europub.co.uk./articles/-A-295530